LIV CEO Scott O’Neil can talk big, but that’s just part of his track record, writes Michael Rosenberg. The reality is that ...

Hims & Hers Health, Inc. is facing existential risk as regulatory uncertainty and margin erosion undermine its growth narrative. HIMS' reliance on compounded GLP-1 drugs has faltered, with regulatory ...